Pharmaceutical Executive December 12, 2024
The latest news for pharma industry insiders.
Trade & Channel Strategies 2024: Access and Channel 2024 Year-in-Review and Preview of 2025
This year’s Trade & Channel Strategies Conference in Philadelphia kicked off with a keynote address from Bill Roth, SVP of IntegriChain’s consulting business, Blue Fin Group, and Pharma Commerce board member. Titled “Access and Channel 2024 Year-in-Review and Preview of 2025”, Roth discussed the current reimbursement landscape, how the evolving site-of-care trends are shaping patient access and channel dynamics, and the influence of cost of goods on channel strategies and profitability.
ASHP Midyear: High Costs of Gene Therapies Present Major Challenges to Implementation
According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58%...
Today's Sponsors
Today's Sponsor